As per the terms of the partnership, the company has been awarded a contract to set up and operate electro-magnetic interference (EMI/EMC) including anechoic chambers, biomaterial, reliability & electrical safety testing facilities on a PPP model within AMTZ.
The company will invest about Rs 85 crore over the next four-five years. The facility is aimed at reducing medical device imports and production cost, the company said.
The domestic medical devices manufacturing is a USD 4 billion industry and nearly 78 per cent of medical devices in the country are imported.
AMTZ will house modern 250-300 independent manufacturing units, each over a built-in ready to use area at a very cost effective long-term lease.
In addition the park will have in-house high investment scientific facilities, including state-of-the-art testing laboratories.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
